Patent application number | Description | Published |
20090087411 | Long-acting interferons and derivatives thereof and methods thereof - A polypeptide and polynucleotides encoding same comprising carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an IFN protein are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 04-02-2009 |
20090270489 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME - A polypeptide and polynucleotides encoding same comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a peptide-of-interest are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 10-29-2009 |
20090275084 | LONG-ACTING EPO POLYPEPTIDES AND DERIVATIVES THEREOF AND METHODS THEREOF - A polypeptide and polynucleotides encoding same comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an EPO peptide are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 11-05-2009 |
20090286733 | LONG-ACTING VETERINARY POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - A polypeptide and polynucleotides comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a non-human peptide-of-interest are disclosed. Pharmaceutical compositions comprising the non-human polypeptides and polynucleotides of the invention and methods of using both human and non-human polypeptides and polynucleotides are also disclosed. | 11-19-2009 |
20090312254 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME - A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a cytokine and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a cytokine are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 12-17-2009 |
20100081614 | LONG-ACTING GROWTH HORMONE AND METHODS OF PRODUCING SAME - A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a growth hormone and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a growth hormone are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 04-01-2010 |
20110286967 | LONG-ACTING INTERFERONS AND DERIVATIVES THEREOF AND METHODS THEREOF - A polypeptide and polynucleotides encoding same comprising carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an IFN protein are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 11-24-2011 |
20120004286 | LONG-ACTING VETERINARY POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - A polypeptide and polynucleotides comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a non-human peptide-of-interest are disclosed. Pharmaceutical compositions comprising the non-human polypeptides and polynucleotides of the invention and methods of using both human and non-human polypeptides and polynucleotides are also disclosed. | 01-05-2012 |
20120015437 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME - A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a cytokine and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a cytokine are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 01-19-2012 |
20120035101 | LONG-ACTING GROWTH HORMONE AND METHODS OF PRODUCING SAME - Use of a growth hormone protein and polynucleotides encoding same comprising an amino-terminal carboxy-terminal peptide (CTP) of chorionic gonadotrophin and two carboxy-terminal chorionic gonadotrophin CTPs attached to the growth hormone in methods of inducing growth or weight gain, method of increasing insulin-like growth factor (IGF-1) levels, and methods of reducing the dosing frequency of a growth hormone in a human subject are disclosed. Pharmaceutical compositions comprising the growth hormone and polynucleotides encoding the growth hormone of the invention and methods of using same are also disclosed. | 02-09-2012 |
20130184207 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - A polypeptide and polynucleotides comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a non-human peptide-of-interest are disclosed. Pharmaceutical compositions comprising the non-human polypeptides and polynucleotides of the invention and methods of using both human and non-human polypeptides and polynucleotides are also disclosed. | 07-18-2013 |
20130303451 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME - A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a cytokine and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a cytokine are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 11-14-2013 |
20140371144 | LONG-ACTING GROWTH HORMONE AND METHODS OF PRODUCING SAME - Use of a growth hormone protein and polynucleotides encoding same comprising an amino-terminal carboxy-terminal peptide (CTP) of chorionic gonadotrophin and two carboxy-terminal chorionic gonadotrophin CTPs attached to the growth hormone in methods of inducing weight loss or body fat reduction, methods of increasing insulin-like growth factor (IGF-1) levels, and methods of reducing the dosing frequency of a growth hormone in a human subject are disclosed. Pharmaceutical compositions comprising the growth hormone and polynucleotides encoding the growth hormone of the invention and methods of using same are also disclosed. | 12-18-2014 |
20150038413 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - A polypeptide and polynucleotides comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a non-human peptide-of-interest are disclosed. Pharmaceutical compositions comprising the non-human polypeptides and polynucleotides of the invention and methods of using both human and non-human polypeptides and polynucleotides are also disclosed. | 02-05-2015 |
20150093358 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - A polypeptide and polynucleotides comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a non-human peptide-of-interest are disclosed. Pharmaceutical compositions comprising the non-human polypeptides and polynucleotides of the invention and methods of using both human and non-human polypeptides and polynucleotides are also discarded. | 04-02-2015 |
20150126444 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - CTP-modified human growth hormone polypeptides and pharmaceutical formulations and pharmaceutical compositions comprising the same and methods of producing, and using the same are disclosed. | 05-07-2015 |
20150126445 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - A polypeptide and polynucleotides comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a non-human peptide-of-interest are disclosed. Pharmaceutical compositions comprising the non-human polypeptides and polynucleotides of the invention and methods of using both human and non-human polypeptides and polynucleotides are also disclosed. | 05-07-2015 |
20150141331 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - A polypeptide and polynucleotides comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a non-human peptide-of-interest are disclosed. Pharmaceutical compositions comprising the non-human polypeptides and polynucleotides of the invention and methods of using both human and non-human polypeptides and polynucleotides are also disclosed. | 05-21-2015 |
20150152155 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME - A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a cytokine and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a cytokine are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 06-04-2015 |
20150158926 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - CTP-modified human growth hormone polypeptides and pharmaceutical formulations and pharmaceutical compositions comprising the same and methods of producing, and using the same are disclosed. | 06-11-2015 |
20150203558 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME - A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a cytokine and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a cytokine are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 07-23-2015 |
Patent application number | Description | Published |
20080233076 | Process for stabilizing ascorbic acid compositions - The present invention relates to a process for inhibiting radical-induced damage to skin involving contacting the skin with a composition containing: a) ascorbic acid and/or a water soluble derivative thereof; b) at least one cinnamic acid derivative; c) water; d) at least one non-aqueous organic solvent; e) at least one pH adjusting agent; and, f) optionally, a surfactant, and wherein the pH of the composition is from about 4 to about 9. | 09-25-2008 |
20080299156 | SKIN CARE COMPOSITIONS CONTAINING A HIGH INTERNAL PHASE EMULSION - The present invention is directed to a skin care composition comprising (a) at least one high internal phase emollient-in-water emulsion; (b) at least one fatty compound, capable of forming a liquid crystal; (c) at least one thickening agent; (d) at least one active agent; and (e) water. Also disclosed is a method of treating skin with the above-disclosed skin care composition. | 12-04-2008 |
20080299157 | SKIN CARE COMPOSITIONS HAVING UNIQUE TEXTURE PROPERTIES - The present invention is directed to a skin care composition comprising (a) at least one high internal phase emollient-in-water emulsion; (b) at least one thickening agent; (c) at least one primary emulsifier chosen from a water-in-silicone emulsifier; (d) at least one non-emulsifying silicone elastomer; (e) at least one active agent; and (f) water. Also disclosed is a method of treating skin with the above-disclosed skin care composition. | 12-04-2008 |
20090053337 | COMPOSITION AND METHOD OF IMPROVING SKIN BARRIER FUNCTION OF COMPROMISED SKIN - A composition and method of improving skin barrier function of compromised skin by applying onto the compromised skin a composition containing: (a) a complex comprised of a metal-copper-antioxidant botanical pigment; (b) an extract of pinus pinaster bark; (c) an extract of pilewort; and (d) a carrier vehicle. | 02-26-2009 |
20100120645 | Fatty acid-free, foaming cosmetic composition and method of use - Disclosed are cosmetic compositions containing a disodium lauryl sulfosuccinate and a hydrophilically modified urethane. Also disclosed are methods for treating a keratinous substrate, such as skin or hair, by applying the cosmetic compositions to the keratinous substrate to, e.g., cleanse the keratinous substrate or deposit a cosmetically acceptable ingredient thereupon. | 05-13-2010 |
20120093748 | TOPICAL PERSONAL CARE AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF - Topical compositions are provided that have 0.5% or more of at least one personal care or pharmaceutical acid, and lightly- to moderately-crosslinked PVP, which is an effective thickener in the low pH systems. In preferred embodiments, the acid is a hydroxy acid and the composition used for personal care, or prescriptive or non-prescriptive medication indications for use on the skin, hair, scalp, foot, or lips. Also provided is the use of the topical compositions to deliver the acid(s) to the skin, hair, scalp, foot, or lips. Especially preferred is a use to reduce irritation and stinging compared to an equivalent compositions not having lightly- to moderately-crosslinked PVP. | 04-19-2012 |
20120196843 | COMPOSITIONS CONTAINING TOPICAL-ACTIVE AGENTS AND PENTYLENEGLYCOL - Disclosed are cosmetic and dermatological compositions containing hydrocortisone or a derivative thereof, a glycol and a thickening or gelling agent, and methods of making and using them. | 08-02-2012 |
20120219515 | SUN-CARE COMPOSITIONS - A sun-care composition having an SPF value of at least (15) containing (a) one or more sun-care actives; (b) a copolymer (or a terpolymer) containing (A) at least one vinyl pyrrolidone monomer and (i) at least one vinyl caprolactam monomer or (ii) at least one vinyl acetate monomer or (B) at least one vinyl caprolactam monomer and at least one vinyl acetate monomer; and (c) a pharmaceutically/cosmetically/dermatologically acceptable vehicle. | 08-30-2012 |
20120294818 | Antiperspirant Compositions - Compositions containing a relatively high concentration of electrolytes and a thickening agent, wherein the thickening agent comprises a strongly swellable, lightly to moderately crosslinked polyvinyl pyrrolidone. The polyvinyl pyrrolidone thickening agent is characterized by an aqueous gel volume of about 15 to 150 ml/g and a Brookfield viscosity of at least 10,000 cps for a 5% aqueous solution at 25° C. | 11-22-2012 |
20130017160 | THICKENING ADDITIVE COMPOSITIONS - A thickening additive composition comprising: (A) a substantially anhydrous solvent system; and (B) a thickening agent, wherein the thickening agent comprises a strongly swellable, lightly to moderately crosslinked polyvinylpyrrolidone. Personal care compositions containing the thickening additive composition are also described. | 01-17-2013 |
Patent application number | Description | Published |
20120230931 | Sun-Care Compositions - A sun-care composition having an SPF value of at least 15 comprising: (a) one or more sun care actives including a ów-resorcinyl triazine compound; (b) an aery late s/octyl acrylamide copolymer; and (c) a pharmaceutically/cosmetically/dermatologically acceptable vehicle. | 09-13-2012 |
20130243703 | SELF ADAPTING POLYMERS FOR ANHYDROUS SUNSCREEN FORMULATIONS - Compositions comprising sun-care actives and self adapting polymers are disclosed. Self adapting polymers align themselves with the hydrophilic group pointing to the surface during application thus delivering an aesthetically pleasing surface to the consumers with a pleasant after feel. These polymers then rearrange upon contact with water so that the hydrophobic groups now point to the surface which then increases the water resistance of the formulation. | 09-19-2013 |
20130309185 | COMPOSITIONS COMPRISING STABILIZED KETO- ENOL UV ABSORBERS - The present application provides compositions having a keto-enol UV absorber, such as avobenzone, stabilized from forming iron complexes. The stabilization is provided by a chelating polymer derived from at least one monomer having lactam or carboxylic acid functionality. In one embodiment, the compositions are sunscreens that resist staining fabrics when washed in hard water. In another embodiment, the compositions also comprise one or more iron-containing adjuvants, such as colorants, dyes, and pigments. By stabilizing the UV absorber, cosmetics can be formulated that impart broad-spectrum UV-A protection to the user. Additional ingredients can be added to the formulation, like other UV absorbers (for even broader UV-A and UV-B protection), moisturizers, actives, conditioning agents, and rheology modifiers. | 11-21-2013 |
20130336905 | COMPOSITIONS OF ENHANCED VISCOSITY, CLARITY, OR BOTH ENHANCED VISCOSITY AND CLARITY - Provided herein are compositions that exhibit enhanced clarity, higher viscosity, or both enhanced clarity and higher viscosity for a wide range of application arts, such as personal care compositions. The compositions have lightly- to moderately-crosslinked PVP and at least one additive. | 12-19-2013 |
20130336912 | ANTIPERSPIRANT/DEODORANT COMPOSITIONS - Disclosed are new and improved antiperspirant/deodorant compositions and methods of reducing perspiration, where the new and improved antiperspirant/deodorant compositions contain a water dispersible organic polymer and can reduce the concentration of active antiperspirant ingredients while maintaining antiperspirant efficacy. | 12-19-2013 |
20140030198 | CLEAR WET SPRAYS AND GELS - Sun-care products are described that protect from UV radiation and do not turn white when applied to wet skin. The sun-care product may comprise (A) a cosmetically-acceptable, substantially non-aqueous vehicle, and (B) a UV active, wherein said non-aqueous vehicle comprises alcohol in an amount of 50% (w/w) or less based on the weight of the sun-care product and an ester wherein said non-aqueous vehicle comprises at least 10%>by weight esters based on the total weight of the non-aqueous vehicle and said sun-care product is substantially non-whitening upon application to wet skin. | 01-30-2014 |
20140242015 | ANTIPERSPIRANT/DEODORANT COMPOSITIONS - Antiperspirant/deodorant compositions have lower, or even zero amounts of aluminium and/or zirconium antiperspirant actives. A polymer having one or more anhydride and/or diacid moieties, such as succinic (maleic) anhydride and/or diacid. The antiperspirant/deodorant compositions comprise a polymer with a non-zero acid value and a cationic species, which may be a cationic polymer, cationic molecule, cation, and/or a cationic carrier. Product are formed for the antiperspirant/deodorant composition, as well as a method of treating perspiration. | 08-28-2014 |